Ocean Biomedical is a new-generation American biopharmaceutical company based in

Providence, Rhode Island Providence is the capital and most populous city of the U.S. state of Rhode Island. One of the oldest cities in New England, it was founded in 1636 by Roger Williams, a Reformed Baptist theologian and religious exile from the Massachusetts Bay ...

. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician

Chirinjeev Kathuria Chirinjeev Kathuria is an Indian-American investor, physician, politician, businessperson, and philanthropist. He was the first Indian-American to run for the US Senate. Kathuria is the co-founder and co-chairman of UpHealth Inc. which went public ...

with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources.

History

In January 2019

co-founded Ocean Biomedical in

Rhode Island Rhode Island (, like ''road'') is a U.S. state, state in the New England region of the Northeastern United States. It is the List of U.S. states by area, smallest U.S. state by area and the List of states and territories of the United States ...

, United States. The company was also co-founded by Jack Elias, who was Dean of Medicine at

Brown University Brown University is a private research university in Providence, Rhode Island. Brown is the seventh-oldest institution of higher education in the United States, founded in 1764 as the College in the English Colony of Rhode Island and Providenc ...

at the time, but currently works as a senior health advisor at Brown. Ocean Biomedical started off as a Brown University biotech "spin-off." The biopharmaceutical company is currently based in Province, Rhode Island. As of 2021 the CEO of the company is Elizabeth Ng. The company works with scientists and research institutions around the world on the research and development projects for new medicines. In 2021 Ocean Biomedical announced plans to go public and filed for a $100 million IPO.

Areas

Ocean Biomedical has worked in areas such as

non-small cell lung cancer Non-small-cell lung cancer (NSCLC) is any type of epithelial lung cancer other than small-cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. As a class, NSCLCs are relatively insensitive to chemotherapy, compared to sm ...

and

pulmonary fibrosis Pulmonary fibrosis is a condition in which the lungs become scarred over time. Symptoms include shortness of breath, a dry cough, feeling tired, weight loss, and nail clubbing. Complications may include pulmonary hypertension, respiratory failu ...

Vaccines

Ocean Biomedical has worked on developing vaccines for tropical diseases such as

malaria Malaria is a mosquito-borne infectious disease that affects humans and other animals. Malaria causes symptoms that typically include fever, tiredness, vomiting, and headaches. In severe cases, it can cause jaundice, seizures, coma, or death. S ...

, as well as for emerging diseases like

COVID-19 Coronavirus disease 2019 (COVID-19) is a contagious disease caused by a virus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first known case was COVID-19 pandemic in Hubei, identified in Wuhan, China, in December ...

. In 2020, the company announced the discovery of a

malaria vaccine A malaria vaccine is a vaccine that is used to prevent malaria. The only approved use of a vaccine outside the EU, as of 2022, is RTS,S, known by the brand name ''Mosquirix''. In October 2021, the WHO for the first time recommended the large-sc ...

Affiliations and partnerships

Ocean Biomedical also has partnered with scientists such as: *Jack Elias (Dean of Biology and Medicine of

Alpert Medical School The Warren Alpert Medical School (formerly known as Brown Medical School, previously known as Brown University School of Medicine) is the medical school of Brown University, located in Providence, Rhode Island. Originally established in 1811, it ...

) *Jake Kurtis (Chair of Pathology and Laboratory Medicine,

) Scientific advisors include Roy Herbst, Wafik el-Deiry, Erol Fikrig, and William H. Koster.

References

External links

LinkedIn
{{Authority control Companies based in Providence, Rhode Island Pharmaceutical companies of the United States Brown University organizations